Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The economic impact of pandemic influenza in the United States: priorities for intervention.

Meltzer MI, Cox NJ, Fukuda K.

Emerg Infect Dis. 1999 Sep-Oct;5(5):659-71. Review.

2.

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

Ryan J, Zoellner Y, Gradl B, Palache B, Medema J.

Vaccine. 2006 Nov 17;24(47-48):6812-22. Epub 2006 Aug 4.

PMID:
17034909
3.

Modelling the health-economic impact of the next influenza pandemic in The Netherlands.

Hak E, Meijboom MJ, Buskens E.

Vaccine. 2006 Nov 10;24(44-46):6756-60. Epub 2006 Jun 9.

PMID:
16797797
4.

Economic analysis of pandemic influenza vaccination strategies in Singapore.

Lee VJ, Tok MY, Chow VT, Phua KH, Ooi EE, Tambyah PA, Chen MI.

PLoS One. 2009 Sep 22;4(9):e7108. doi: 10.1371/journal.pone.0007108.

5.

The annual impact of seasonal influenza in the US: measuring disease burden and costs.

Molinari NA, Ortega-Sanchez IR, Messonnier ML, Thompson WW, Wortley PM, Weintraub E, Bridges CB.

Vaccine. 2007 Jun 28;25(27):5086-96. Epub 2007 Apr 20.

PMID:
17544181
6.

Effectiveness of influenza vaccine in the elderly.

Nichol KL, Margolis KL, Wouremna J, von Sternberg T.

Gerontology. 1996;42(5):274-9.

PMID:
8940650
7.

An economic analysis of annual influenza vaccination of children.

Meltzer MI, Neuzil KM, Griffin MR, Fukuda K.

Vaccine. 2005 Jan 11;23(8):1004-14.

PMID:
15620473
8.

Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.

Clements KM, Chancellor J, Nichol K, DeLong K, Thompson D.

Value Health. 2011 Sep-Oct;14(6):800-11. doi: 10.1016/j.jval.2011.03.005.

9.

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.

Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ.

Vaccine. 2008 Jun 2;26(23):2841-8. doi: 10.1016/j.vaccine.2008.03.046. Epub 2008 May 6.

PMID:
18462851
10.

Influenza pandemic preparedness in France: modelling the impact of interventions.

Doyle A, Bonmarin I, Lévy-Bruhl D, Le Strat Y, Desenclos JC.

J Epidemiol Community Health. 2006 May;60(5):399-404.

11.

[A possible scenario of pandemic influenza in Italy].

Greco D, Rizzuto E, Paramatti D.

Ig Sanita Pubbl. 2006 Mar-Apr;62(2):201-14. Italian.

PMID:
17206190
12.

Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.

Zhou F, Shefer A, Weinbaum C, McCauley M, Kong Y.

Vaccine. 2007 May 4;25(18):3581-7. Epub 2007 Jan 25.

PMID:
17306908
13.

Population-wide benefits of routine vaccination of children against influenza.

Weycker D, Edelsberg J, Halloran ME, Longini IM Jr, Nizam A, Ciuryla V, Oster G.

Vaccine. 2005 Jan 26;23(10):1284-93.

PMID:
15652671
14.

Economic consequences to society of pandemic H1N1 influenza 2009 - preliminary results for Sweden.

Brouwers L, Cakici B, Camitz M, Tegnell A, Boman M.

Euro Surveill. 2009 Sep 17;14(37). pii: 19333.

15.

Public health. Who should get influenza vaccine when not all can?

Emanuel EJ, Wertheimer A.

Science. 2006 May 12;312(5775):854-5. No abstract available.

PMID:
16690847
16.

Containing pandemic influenza with antiviral agents.

Longini IM Jr, Halloran ME, Nizam A, Yang Y.

Am J Epidemiol. 2004 Apr 1;159(7):623-33.

PMID:
15033640
17.

Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.

Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ.

Am J Prev Med. 2006 Jul;31(1):72-9. Review.

PMID:
16777545
18.

Update: influenza activity--United States, 2010-11 season, and composition of the 2011-12 influenza vaccine.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jun 3;60(21):705-12.

19.

Effects of adverse events on the projected population benefits and cost-effectiveness of using live attenuated influenza vaccine in children aged 6 months to 4 years.

Prosser LA, Meltzer MI, Fiore A, Epperson S, Bridges CB, Hinrichsen V, Lieu TA.

Arch Pediatr Adolesc Med. 2011 Feb;165(2):112-8. doi: 10.1001/archpediatrics.2010.182. Epub 2010 Oct 4.

PMID:
20921341
20.

Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.

Mylius SD, Hagenaars TJ, Lugnér AK, Wallinga J.

Vaccine. 2008 Jul 4;26(29-30):3742-9. doi: 10.1016/j.vaccine.2008.04.043. Epub 2008 May 7.

PMID:
18524428

Supplemental Content

Support Center